Skip to main content
. Author manuscript; available in PMC: 2019 Feb 7.
Published in final edited form as: Benef Microbes. 2018 Apr 10;9(3):345–355. doi: 10.3920/BM2017.0059

Table 2.

Relationship of Stool and Urine TFF3 to Gastrointestinal Symptoms and Stool Characteristics in Females with Irritable Bowel Syndrome

Symptomsa Stool Characteristicsb
Abdominal Pain Constipation Diarrhea Intestinal Gas Urgency % Very Loose % Loose % Hard % Very Hard Number of Stools
Log of Stool TFF3
  Simple correlation 0.05 −0.24* 0.22* 0.18  0.13  0.32**  0.19  −0.06  −0.07  0.22*
  Partial correlationC 0.03 −0.26* 0.20 0.16  0.14  0.29**  0.18  −0.09  −0.11  0.15
  Simple correlation, among participants not using hormone contraceptive 0.13 −0.22 0.17 0.19  0.18  0.22  0.16  −0.04  −0.10  0.07
  Simple correlation, among hormone contraceptive users −0.26 −0.35 0.31 0.08  0.03  0.55**  0.25  −0.28  −0.13  0.39*
Urine TFF3
  Simple correlation −0.06 0.01 −0.09 −0.01  −0.08  −0.13  0.01  −0.05  0.03  −0.22
  Partial correlationC 0.01 −0.05 −0.20 −0.02  −0.22  −0.22  −0.10  −0.01  0.01  −0.10
  Simple correlation, among participants not using hormone contraceptive −0.04 −0.08 −0.06 0.03 0.05 −0.03 0.02 −0.06 −0.00 0.07
  Simple correlation, among hormone contraceptive users 0.02 −0.06 −0.40* −0.03 −0.39 −0.41* −0.20 0.01 0.02 −0.20

Notes. TFF3 = Trefoil factor3. No Hormone Contraceptive (n = 45); Hormone Contraceptive (n = 24); Stool TFF3, n = 85.

a

Symptoms are measured as the % of days reported as moderate to severe on a 28-day diary.

b

Stool characteristics are measured as percent of days with very loose stools, loose stools, etc.

C

Partial correlation controlling for hormone contraceptive. Pearson R was used.

*

p < 0.05

**

p < 0.01